The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 05, 2018

Filed:

Oct. 24, 2014
Applicant:

Psioxus Therapeutics Limited, Oxfordshire, GB;

Inventors:

Brian Robert Champion, Oxfordshire, GB;

Alice Claire Noel Brown, Oxfordshire, GB;

Kerry David Fisher, Oxfordshire, GB;

Tamara Nicolson, London, GB;

Assignee:

Psioxus Therapeutics Limited, Oxfordshire, GB;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/761 (2015.01); A61K 39/00 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/761 (2013.01); A61K 39/0011 (2013.01); C12N 7/00 (2013.01); A61K 2039/5256 (2013.01); C12N 2710/10332 (2013.01); C12N 2710/10343 (2013.01);
Abstract

The present disclosure relates to a group B adenovirus comprising a sequence of formula (I): 5'ITR-B1-BAB2-BX-BB-BY-B3-3′ITR wherein: B1 is bond or comprises: E1A, E1B or E1AE1B; BA comprises: E2B-L1-L2-L3-E2A-L4; B2 is a bond or comprises: E3; BX is a bond or a DNA sequence comprising: a restriction site, one or more transgenes or both; BB comprises L5; BY is a bond or a DNA sequence comprising: a restriction site, one or more transgenes or both; B3 is a bond or comprises: E4; wherein at least one of BX or BY is not a bond, pharmaceutical compositions comprising the same and use of the viruses and compositions in treatment, particularly in the treatment of cancer. The disclosure also extends to plasmids and processes employed to prepare the said viruses.


Find Patent Forward Citations

Loading…